NO20041007L - Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat - Google Patents
Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparatInfo
- Publication number
- NO20041007L NO20041007L NO20041007A NO20041007A NO20041007L NO 20041007 L NO20041007 L NO 20041007L NO 20041007 A NO20041007 A NO 20041007A NO 20041007 A NO20041007 A NO 20041007A NO 20041007 L NO20041007 L NO 20041007L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical composition
- oxypurine nucleosides
- oxypurine
- nucleosides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28921494A | 1994-08-12 | 1994-08-12 | |
PCT/US1995/010078 WO1996004923A1 (en) | 1994-08-12 | 1995-08-08 | Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20041007L true NO20041007L (no) | 2004-03-10 |
Family
ID=23110539
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO970631A NO970631L (no) | 1994-08-12 | 1997-02-11 | Fremgangsmåter for behandling av sepsis eller betennelsessykdommer med oxypurin-nukleosider |
NO20016068A NO317199B1 (no) | 1994-08-12 | 2001-12-12 | Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat for redusering av inflammasjon i et dyr |
NO20041007A NO20041007L (no) | 1994-08-12 | 2004-03-10 | Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO970631A NO970631L (no) | 1994-08-12 | 1997-02-11 | Fremgangsmåter for behandling av sepsis eller betennelsessykdommer med oxypurin-nukleosider |
NO20016068A NO317199B1 (no) | 1994-08-12 | 2001-12-12 | Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat for redusering av inflammasjon i et dyr |
Country Status (12)
Country | Link |
---|---|
US (1) | US20040235782A1 (no) |
EP (2) | EP1157698A3 (no) |
JP (2) | JPH10507441A (no) |
KR (1) | KR100290129B1 (no) |
AU (1) | AU712835B2 (no) |
CA (1) | CA2197205A1 (no) |
FI (1) | FI970588A (no) |
IL (1) | IL114887A0 (no) |
NO (3) | NO970631L (no) |
RU (1) | RU2203669C2 (no) |
WO (1) | WO1996004923A1 (no) |
ZA (1) | ZA956679B (no) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19818044A1 (de) * | 1998-04-22 | 1999-10-28 | Klinge Co Chem Pharm Fab | Verwendung von Vitamin-PP-Verbindungen |
US6518277B1 (en) * | 2000-04-25 | 2003-02-11 | Icos Corporation | Inhibitors of human phosphatidylinositol 3-kinase delta |
US6667300B2 (en) | 2000-04-25 | 2003-12-23 | Icos Corporation | Inhibitors of human phosphatidylinositol 3-kinase delta |
AU2002358616A1 (en) * | 2001-12-07 | 2003-06-17 | Intercell Ag | Immunostimulatory oligodeoxynucleotides |
PT2042504E (pt) | 2002-09-30 | 2011-09-07 | Bayer Schering Pharma Ag | Derivados da azolepirimidina fundida |
US6997018B2 (en) | 2003-06-02 | 2006-02-14 | Ferro Corporation | Method of micro and nano texturing glass |
ES2605792T3 (es) | 2004-05-13 | 2017-03-16 | Icos Corporation | Quinazolinona usada como inhibidor de la fosfatidilinositol 3-quinasa delta humana |
US9186406B2 (en) | 2007-08-16 | 2015-11-17 | The Henry M. Jackson Foundation for Advancement of Military Medicine, Inc. | Compositions containing nucleosides and manganese and their uses |
CA2975473C (en) | 2008-11-13 | 2021-01-19 | Gilead Calistoga Llc | Therapies for hematologic malignancies |
US9492449B2 (en) | 2008-11-13 | 2016-11-15 | Gilead Calistoga Llc | Therapies for hematologic malignancies |
WO2010111432A1 (en) | 2009-03-24 | 2010-09-30 | Calistoga Pharmaceuticals Inc. | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
WO2010123931A1 (en) | 2009-04-20 | 2010-10-28 | Calistoga Pharmaceuticals Inc. | Methods of treatment for solid tumors |
EA201270184A1 (ru) | 2009-07-21 | 2012-08-30 | ГИЛИЭД КАЛИСТОГА ЭлЭлСи | Лечение расстройств печени ингибиторами pi3k |
BR112012027740B1 (pt) | 2010-04-29 | 2021-02-17 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | composições contendo nucleosídeos de purina e pirimidina, peptídeos e maganês e seus usos |
PL2834241T3 (pl) | 2012-03-05 | 2021-07-12 | Gilead Calistoga Llc | Formy polimorficzne (s)-2-(1-(9h-puryn-6-yloamino)propylo)-5-fluoro-3-fenylochinazolin-4(3h)-onu |
WO2015095605A1 (en) | 2013-12-20 | 2015-06-25 | Gilead Calistoga Llc | Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one |
JP2017502021A (ja) | 2013-12-20 | 2017-01-19 | ギリアード カリストガ エルエルシー | ホスファチジルイノシトール3−キナーゼ阻害剤のためのプロセス方法 |
JP6455995B2 (ja) | 2014-06-13 | 2019-01-23 | ギリアード サイエンシーズ, インコーポレイテッド | ホスファチジルイノシトール3−キナーゼ阻害剤 |
CN116634871A (zh) * | 2020-08-24 | 2023-08-22 | 阿达玛马克西姆有限公司 | 农药化合物和组合物、使用方法及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2100655C (en) * | 1991-02-08 | 2004-02-03 | Reid W. Von Borstel | Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
US5320846A (en) * | 1991-04-17 | 1994-06-14 | New England Deaconess Hospital Corp. | Method and composition for testing patients with metabolic depleting diseases |
-
1995
- 1995-08-08 JP JP8507462A patent/JPH10507441A/ja not_active Ceased
- 1995-08-08 EP EP01117657A patent/EP1157698A3/en not_active Withdrawn
- 1995-08-08 EP EP95929425A patent/EP0771204A4/en not_active Withdrawn
- 1995-08-08 RU RU97103981/13A patent/RU2203669C2/ru not_active IP Right Cessation
- 1995-08-08 WO PCT/US1995/010078 patent/WO1996004923A1/en not_active Application Discontinuation
- 1995-08-08 AU AU32784/95A patent/AU712835B2/en not_active Ceased
- 1995-08-08 KR KR1019970700921A patent/KR100290129B1/ko not_active IP Right Cessation
- 1995-08-08 CA CA002197205A patent/CA2197205A1/en not_active Abandoned
- 1995-08-09 IL IL11488795A patent/IL114887A0/xx not_active IP Right Cessation
- 1995-08-10 ZA ZA9506679A patent/ZA956679B/xx unknown
-
1997
- 1997-02-11 NO NO970631A patent/NO970631L/no not_active Application Discontinuation
- 1997-02-12 FI FI970588A patent/FI970588A/fi not_active IP Right Cessation
-
2001
- 2001-12-12 NO NO20016068A patent/NO317199B1/no not_active IP Right Cessation
-
2004
- 2004-03-10 NO NO20041007A patent/NO20041007L/no not_active Application Discontinuation
- 2004-06-25 US US10/875,332 patent/US20040235782A1/en not_active Abandoned
-
2009
- 2009-06-02 JP JP2009133542A patent/JP2009221221A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1157698A2 (en) | 2001-11-28 |
WO1996004923A1 (en) | 1996-02-22 |
NO317199B1 (no) | 2004-09-13 |
RU2203669C2 (ru) | 2003-05-10 |
EP0771204A4 (en) | 1999-10-20 |
IL114887A0 (en) | 1995-12-08 |
AU3278495A (en) | 1996-03-07 |
EP1157698A3 (en) | 2002-05-02 |
JP2009221221A (ja) | 2009-10-01 |
NO970631L (no) | 1997-04-11 |
NO20016068D0 (no) | 2001-12-12 |
KR100290129B1 (ko) | 2001-05-15 |
CA2197205A1 (en) | 1996-02-22 |
AU712835B2 (en) | 1999-11-18 |
NO970631D0 (no) | 1997-02-11 |
JPH10507441A (ja) | 1998-07-21 |
US20040235782A1 (en) | 2004-11-25 |
FI970588A0 (fi) | 1997-02-12 |
NO20016068L (no) | 1997-04-11 |
KR970704457A (ko) | 1997-09-06 |
ZA956679B (en) | 1997-02-10 |
FI970588A (fi) | 1997-04-11 |
EP0771204A1 (en) | 1997-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO973612D0 (no) | Nytt farmasöytisk preparat | |
NO943888D0 (no) | Farmasöytisk preparat | |
NO973938D0 (no) | Farmasöytisk preparat av piperdinoalkanolforbindelser | |
NO941719D0 (no) | Farmasöytisk preparat med regulert frigjöringsvirkning | |
NO921958L (no) | Farmasoeytisk preparat | |
NO922006D0 (no) | Farmasoeytisk preparat | |
NO20073430L (no) | Anvendelse av et antistoff mot interleukin-6-reseptor for fremstilling av et farmasoytisk preparat | |
NO20004345D0 (no) | Farmasøytisk sammensetning | |
NO20041007L (no) | Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat | |
NO308394B1 (no) | Oralt preparat | |
NO973610D0 (no) | Nytt farmasöytisk preparat | |
BR9507768A (pt) | Composição farmacêutica | |
LV11727A (lv) | Farmaceitiska kompozicija | |
FI973280A0 (fi) | Farmaseuttinen koostumus | |
NO973611D0 (no) | Nytt farmasöytisk preparat | |
NO950950D0 (no) | Farmasöytisk preparat | |
NO20003393D0 (no) | FremgangsmÕte for fremstilling av en farmasøytisk formulering | |
BR9605777A (pt) | Composição farmacêutica | |
BR9605131A (pt) | Composição farmacêutica | |
NO931014D0 (no) | Farmasoeytisk preparat | |
NO179817C (no) | Anvendelse av 4,9,11-trien-steroider for fremstilling av et farmasöytisk preparat | |
NO921691D0 (no) | Farmasoeytisk preparat | |
NO920647D0 (no) | Nasalt farmasoeytisk preparat | |
SE9402437D0 (sv) | Pharmaceutical composition | |
KR960016881A (ko) | 제약 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |